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Abstract
OBJECTIVES—Describe prevalence of diabetes mellitus among centenarians.
DESIGN—Cross-sectional, population-based.
SETTING—44 counties in northern Georgia.
PARTICIPANTS—244 centenarians (aged 98-108, 15.8% men, 20.5% African-American, 38.0%
community-dwelling) from the Georgia Centenarian Study (2001-2009).
MEASUREMENTS—Nonfasting blood samples assessed HbA1c and relevant clinical
parameters. Demographic, diagnosis, and diabetes complications covariates were assessed.
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RESULTS—12.5% of centenarians were known to have diabetes. Diabetes was more prevalent
among African-Americans (27.7%) than Whites (8.6%, p=.0002). There were no differences
between men (16.7%) and women (11.7%, p=.414), centenarians living in the community (10.2%)
or facilities (13.9%, p=.540). Diabetes was more prevalent among overweight/obese (23.1%) than
non-overweight (7.1%, p=.002) centenarians. Anemia (78.6% versus 48.3%, p=.004) and
hypertension (79.3% versus 58.6%, p=.041) were more prevalent among centenarians with
diabetes than without and centenarians with diabetes took more nonhypoglycemic medications(8.6
versus 7.0, p=.023). No centenarians with hemoglobin A1c < 6.5% had random serum glucose
levels above 200 mg/dl. Diabetes was not associated with 12 month all-cause mortality, visual
impairment, amputations, cardiovascular disease or neuropathy. 37% of centenarians reported
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University, Philadelphia, PA 19122. Tel. (215) 204-7881. Fax. (215) 204-1854. adavey@temple.edu..
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onset before age 80 (survivors), 47% between 80 and 97 years (delayers) and 15% age 98 or older
(escapers).
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CONCLUSION—Diabetes is a risk factor for cardiovascular disease and mortality, but is seen in
persons who live into very old age. Aside from higher rates of anemia and use of more
medications, few clinical correlates of diabetes were observed in centenarians.
Keywords
Centenarians; Type 2 diabetes mellitus; Hemoglobin A1c

INTRODUCTION
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Increases in life expectancy of 2.2 years per decade suggest that fully one-half of all children
born today could reach their 100th birthday1. Epidemiologic studies have revealed a
progressive increase in diabetes mellitus prevalence (predominantly type 2 diabetes) among
older adults2, 3, but little is known about prevalence among centenarians, especially when
diabetes mellitus is defined bycurrently accepted measures such as hemoglobin A1c
(HbA1c)4, 5. Increasing survival afteronset of diabetes may be due to improved therapeutic
remedies (pharmacological, dietary treatments and physical activity) and general increasesin
life expectancy6. There is considerable variation in estimates of diabetes prevalence in older
adults (from 10% to 38%) as a function of the year of measurement, sample composition
and the diagnostic criteria employed7, 8.
Few studies have characterized the prevalence of diabetes among persons who have
survived into very old age (exceptional survivors). The Danish Centenarian Study reports a
10% prevalence of diabetes in Danish centenarians, but provides nodescription of
prevalence variations across characteristics such as sex, race, or risk variables9. The current
study describes prevalence of diabetesin centenarians, examines variations by key
demographic and health variables anddescribes the associations of HbA1c with relevant
clinical parameters.
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Historically, diabetes has been diagnosed on the basis of plasma glucose levels. Individuals
with fasting glucose levels ≥126 mg/dl (7.0 mmol/l) or non-fasting glucose levels >200 mg/
dl (11.1 mmol/l) are considered to have diabetes4. These cut-points were established because
retinopathy was found to be relatively absent in individuals with glucose levels below these
levels. Above these levels, prevalent retinopathy increases in a linear fashion;there are no
age differences in diagnostic cut-points,only in treatment4, 5. Many patients accurately selfreport having a diagnosis of diabetes 10, 11,but it is estimated that up to 26% of diabetes
cases are undiagnosed2, making objective measures preferable. Recently, a longer-term
measure of glucose levels, glycated hemoglobin (HbA1c), has been used to assess glucose
levels, and risk of diabetes-associated retinopathy. Current guidelines suggest that HbA1c
≥6.5% indicates diabetes and this cut-point does not differ by age4. HbA1clevel is
considered an important monitoring tool in treating patients with diabetes12. Several
previous studies have analyzedthe relationship between blood glucoseand HbA1c in different
populations13. However, analysis of the relationship between HbA1c and relevant clinical
parameters is not currently available in the research literature.

METHODS
Sample and Design
A population-based sample of 244 centenarians (n=135) and near-centenarians (n=109) from
Phase III of the Georgia Centenarian Study14 (GCS, 2001-2008) was employed,

J Am Geriatr Soc. Author manuscript; available in PMC 2013 March 1.
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representing over 19% of that total estimated population from a 44 county region of
northeast Georgia15. Ages ranged from 98 to 108 years, 15.8% were men, 20.5% were
African-American, and 38.0% lived in community settings. The study was approved by the
University of Georgia Institutional Review Board on Human Subjects. Inclusion criteria for
the GCS were verified age-eligibility and consent to blood draw, with no exclusions.
Procedures
The multidisciplinary nature of the GCS required that a data collection team meet
centenarians at their residence. Data collection was divided into four sessions, each of which
could be completed within two hours. On the first visit, after explaining the study aims and
obtaining informed written consent, demographics, family longevity and mental status
information was collected. A second session included a blood draw and a physical
examination. The third and fourth sessions focused on neuropsychological and physical
functioning, respectively16.
Measures
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Outcomes—Individuals were considered to have diabetes if their HbA1c levels were
≥6.5%4 or they were currently taking hypoglycemic medication. Only five centenarians
were taking insulin,all at low dose. Information about disease diagnoses across a variety of
organ systems, including diabetes, was obtained. Multiple sources could be consulted to
obtain this information including self-report (n=38, 15.6%), proxy report (n=119, 48.8%),
healthcare professionals (n=12, 4.9%), and medical records (n=138, 56.6%).

NIH-PA Author Manuscript

Covariates—Demographic covariates included sex (men/women), race (White/
AfricanAmerican) and residential status (community/facility). Age was calculated based on
interview and birth dates. Education was recorded in years. Information was obtained
regarding lifetime alcohol and tobacco use. Based on low frequencies of current use, these
values were dichotomized as current/ever=1 versus never=0. Number of medications,
excluding those for hyperglycemia, was recorded. Using American Hypertension
Association guidelines, the pulse pressure method was used to measure sitting systolic
(SBP) and diastolic blood pressure (DBP) in the right arm with proper cuff size, unless
participants were not able to sit or right-arm measurement was precluded. Supine BP
measurement was employed if participantswere confined to bed or could not sitcomfortably.
There were no differences in BP values, systolic or diastolic, based on sitting (n=215) or
supine (n=26) measurement classification (p=.644 and .799 for systolic and diastolic,
respectively) and all findings were the same when controlling statistically for sitting or
standing measurement in preliminary analyses. Presence of hypertension was determined by
presence ofSBP≥140mmHg, DBP≥90, current reported hypertension diagnosis, or current
treatment with antihypertensive medications (any=1 versus none=0). Body weight and
height were directly measured by interviewers, obtained from charts or via self-report. If the
centenarian was bedbound or had kyphosis, height was estimated from knee height using
standard formulas17. Body mass index (BMI) was calculated as weight (pounds)/height
(inches)2×703. BMI categories were based on the National Institutes of Health18 guidelines,
and focused on non-overweight (≤25kg/m2) or overweight/obese (>25kg/m2). There were
insufficient numbers of obese centenarians (n=13) to consider finer distinctions as a function
of BMI. Extent of visual impairment was coded based on acuity on a Snellen chart (mild=at
least 20/60, moderate=between 20/60 and 20/160, severe=less than 20/160 or unable to
complete task due to vision problems). Presence of any amputations was noted during the
examination and coded dichotomously (yes=1, no=0). Sensory testing was conducted on left
and right feet using a 10g monofilament and evidence of neuropathy in either foot was
coded dichotomously (yes=1, no=0). Diagnoses of peripheral artery disease and congestive
heart failure were determined as part of the medical examination. Cognitive functioning was
J Am Geriatr Soc. Author manuscript; available in PMC 2013 March 1.
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assessed using the Global Deterioration Rating Scale19Presence of an apolipoprotein-E-ε4
allele (APOE-ε4, yes=1, no=0) was also recorded. Anemia was determined by hemoglobin
status (<13g/dl for men and <12g/dl for women). All-cause mortality was recorded for the
12-month period following interview. .
Blood samples were collected at the centenarians’ residences at the time of the physical
examination. Due to varying times of collection and the frail nature of some participants,
blood was collected in the non-fasted state. Blood samples were assessed(Lab Corp, Inc.,
Burlington, NC) for HbA1c, glucose, creatinine, blood urea nitrogen (BUN), alanine
aminotransferase (AST) aspartate aminotransferase (ALT), ferritin, and c-reactive protein
(CRP, mg/l). HbA1c values were not obtained for 13 participants for the following reasons:
(1) insufficient blood draw volume (n=9), (2) lab did not return HbA1c value without
explanation given (n=3), and (3) sample too hemolyzed for HbA1c analysis (n=1).
Statistical Analysis
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All analyses were performed using STATA1120. Fisher’s exact test was used to evaluate
associations between diabetes status and dichotomous variables, and Mann-Whitney test
used was to evaluate associations between diabetes status and ordinal variables.
Independent-samples t-tests were used to evaluate associations between diabetes and
continuous variables (with equal or unequal variances as indicated by a robust Levene’stest
of homogeneity of variance). James’s test was used to evaluate omnibus differences in
predictors by diabetes status. A Mantel-Haenzel test was used to determine whether the
association between diabetesand race persisted when controlling for overweight status.
Ordinary least squares (OLS)regression with robust standard errors was used to model the
associationsbetween predictor variables and HbA1c.

RESULTS
Diabetes Prevalence
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Overall, 29 of 232 (12.5%) of centenarians had diabetesas indicated by HbA1c levels ≥6.5%
and/or use of hypoglycemic medications, and no centenarians with HbA1c levels <6.5% had
random plasma glucose levels ≥200 mg/dl. In order to determine the morbidity profiles for
diabetes21, those with a known diagnosis of diabetes (n=21) were asked to provide
information about year of onset. Ten participants were on only oral hypoglycemics, three
were on oral hypoglycemics and low dose insulin, and two were on low dose insulin only.
All five individuals on low-dose insulin were diagnosed in their 70s or 80s. Based on 19 (of
21 diagnosed) cases with complete data for this question, 7 reported age of onset before 80
years (survivors), 9 reported onset between 80 and 97 years (delayers), and 3 reported onset
at 98 years or older (escapers). Mean disease duration for centenarians with diagnosed
diabeteswas 16.8 years (SD=13.5).
Zero-Order Associations with Diabetes
Table 1 presents descriptive statistics by diabetes status. James’s test22, an extension of
Hotelling’s T2 allowing for heterogeneous variances used as a protection scheme for testing
multiple variables was statistically significant (F(30,33.4)=2.47, p=0.006). There was no
difference in prevalence between men (16.7%) and women (11.7%, p=.414) or by
community (10.2%) versus institutional residence (13.9%, p=.540), but African-Americans
(27.7%) were more likely than Whites (8.6%, p=.002) to have diabetes, and diabetes was
more prevalent among overweight/obese centenarians (23.1%) than those who were not
overweight/obese (7.1%, p=.002). A Mantel-Haenzel test indicated that the relative risk
(odds ratio) of diabetes remained higher among African-Americans than Whites controlling
for overweight status (OR=3.30, p=.006).Two additional analyses (not presented) were
J Am Geriatr Soc. Author manuscript; available in PMC 2013 March 1.
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performed to examine potential differences in the association between HbA1c levels between
Whites and African-Americans. First, we evaluated effect modification with a race×HbA1c
interaction term (p=.331). Second, as suggested by previous work investigating whether
HbA1c is equally useful as a criterion across ethnic groups23, 24, we estimated a pair of
logistic regression models predicting diagnosis of diabetes from HbA1c levels separately for
Whites and African-Americans. Solving for the values of HbA1c at which an individual was
predicted to be more likely than not to have diabetes yielded predicted values of 7.40% for
Whites and 7.35% for African-Americans, suggesting that the associations between HbA1c
and diagnosed diabetes appear robust across Whites and African-Americans.
Anemia was more prevalent among centenarians with (78.6%) than without (48.3%)
diabetes (p=.004), as was hypertension (79.3% versus 58.6%, p=.041). There were no
differences in diabetes prevalence as a function of lifetime alcohol or tobacco use, or the
presence of APOE-ε4. Diabeteswas not associated with 12-month all-cause mortality, extent
of functional visual impairment, amputations, neuropathy of the feet, or global cognitive
functioning. Age was not associated with diabetes, but more educated centenarians were less
likely to have diabetes. Diabetic centenarians took significantly more non-hypoglycemic
medications than non-diabetic centenarians, but there were no differences in the probability
of NSAID use.
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Non-fasting serum glucose levels were higher among diabetic centenarians compared to
those without diabetesand hemoglobin levels were significantly lower among diabetic
centenarians with diabetes compared to those without diabetes. There were no differences
between centenarians with and without diabetes in levels of serum creatinine, CRP, ferritin,
BUN, AST, or ALT(Table 1).
Multivariate Predictors of HbA1c
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In order to identify the multivariate predictors of HbA1cstatus among centenarians, an OLS
regression model with bootstrapped standard errors was used including age, sex, race,
institutional residence, educational attainment, BMI, lifetime use of alcohol, tobacco,
hypertension, APOE-ε4, and CRP (Table 2). Further model building and trimming
procedures did not alter the substantive conclusions. The full model (Wald χ2(11)=38.92,
p<.001) accounted for 22.3% of the variance in HbA1c and indicated that African-Americans
had higher HbA1cthan Whites (b=0.400, p=.022),individuals with higher BMIs had higher
HbA1c(b=0.044, p<.001), and individuals who had ever used tobacco had lower HbA1c (b=
−0.237, p=0.015). Only a small proportion of the sample (28.2%) reported ever having used
tobacco and just 2.9% were current users. Those who reported ever using tobacco were
roughly evenly split between <10 years of tobacco use (51.5%) and 10+ years of tobacco use
(48.5%). When years of tobacco use (none, <10 years, 10+ years) was included in the
model, the coefficients remained negative. There was no evidence of effect modification for
lifetime tobacco use.

DISCUSSION
This study provides the first estimates of diabetes prevalence among centenarians using
current standards of HbA1c measurement in a population-based sample. It is interesting to
note that the distinction between type 1 and type 2 diabetes was not recognized until the
current cohort of centenarians had reached adulthood25. Findings indicate that diabetesis
prevalent, even among extreme survivors. Several factors associated with risk for diabetes in
younger populations appear inthe second century of life, specifically differences by race,
overweight status, and educational attainment2. In contrast to younger populations12, 26,
relatively fewerdiabetes-related complications were seenin centenarians.

J Am Geriatr Soc. Author manuscript; available in PMC 2013 March 1.
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Prevalence of anemia is higher (and correspondingly, hemoglobin levels are lower) among
centenarians with diabetes than those without, a finding observed with younger
populations27. These differences seem not be attributed to medications, as use of nonsteroidal anti-inflammatory medications between individuals with and without diabetes was
similar and only two diabetic individuals were taking glitazones, One plausible mechanism
may be related to the effects of diabetes on renal functioning and development of chronic
kidney disease. Serum creatinine levels did not differ significantly between individuals with
and without diabetes, however, although creatinine levels also vary as a function of age, sex,
race, and BMI, and so are unlikely to be a reliable indicator of kidney disease in this age
group. Direct measurement of creatinine clearance such as through 24-hour urine collection
was not available, and standard formulas to estimate creatinine clearance have either been
standardized using individuals selected for kidney disease28 or in much younger
populations29, 30.
Prevalence of hypertension and total number of medications were higher among
centenarians with diabetes than those without. However, no differences were observed in
12-month all-cause mortality, functional vision impairment, amputations, neuropathy of the
feet, or cognitive functioning, despite the fact that, on average, the diagnosedcentenarians
have lived with diabetes for more than 15 years, and in onecase for more than 50 years.
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Sample size is small. However,the current population of centenarians also is very small, and
we recruited nearly 20% of the entire estimatedpopulation in this targeted geographic area.
Our study employed numbers of centenarians which are comparable with the Health and
Retirement Study (n=143) and the 2004 wave of the National Long Term Care Survey
(n=253) which oversampled individuals 95 years of age and older. Use of a single measure
of BP is a limitation, but other indices of hypertension were also employed and results were
not affected by different operationalizations (SBPor DBP, unadjusted or adjusted for
treatment, and mean arterial pressure), nor were there associations of diabetes with
peripheral artery disease or congestive heart failure. Prevalence of other cardiovascular
disease variables was too low to include them in meaningful analyses. These included
angina (n=0), coronary artery disease (n=4), and cardiomegaly (n=1). Prevalence of
cognitive impairment in this aged population is high16, rendering self-report data suspect for
many individuals. Further, many individuals have outlived many of the most reliable
potential sources of proxy information. To reduce these potential problems, more objective
measures (e.g., observed height, BP, serum values, and recording medication information
from prescription bottles) were used to the fullest extent possible.

CONCLUSION
NIH-PA Author Manuscript

A substantial proportion of centenarians have diabetes, most commonly with age of onset in
their 80s. Given the typically long duration of diabetes for this rapidly growing population,
future research should carefully address potential consequences of diabetes among
centenarians. In younger populations, these includephysical disability, cognitive impairment,
and indicators of cardiovascular and renal functioning. It is notable that in this study we
found relatively few complications associated with diabetes. It will be important to replicate
these findings as larger samples of centenarians become available in order to disentangle
several possibilities. It can be difficult to distinguish between complications related to one
specific disease in a group of centenarians characterized by multimorbidity. Centenarians
typically reach this age with considerable burden of disease, such that the additional
consequences of diabetes may be less important than for younger, less impaired persons.
Alternatively, because diabetes is associated with both older age and mortality, there may be
important selective forces at work such that the only centenarians who are able to attain this
age in the presence of diseases such as diabetes are, by definition, those with relatively

J Am Geriatr Soc. Author manuscript; available in PMC 2013 March 1.
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fewer complications.This kind of selective mortality may also explain the finding of lower
HbA1c levels among former smokers. Centenarians who smoked, did so relatively little.
Thus, it is possible that many smokers with diabetesdied at a younger age. Paradoxically, we
may need to direct attention to younger individuals with diabetes to address these questions
raised with centenarians, and we may need to do so within the context of longitudinal
studies. For example, one simple hypothesis is that individuals with diabetes whose
physicians make more effective decisions with regard to treatment and monitoring of risk
factors are able to live with diabetes free of complications for longer periods.
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203
201
193
192
192
192
192
203
203
187
204
204
203

Any APOE ε4*

Anemia*

Overweight/Obese*

†
Visual Impairment

Mild

Moderate

Severe

All-Cause Mortality within 12
Months*

Amputations*

Neuropathy*

Peripheral Artery Disease*

Congestive Heart Failure*

Non-Steroidal Anti-Inflammatory
Medication*

Education (Years)

‡

203

Hypertension (observed,
diagnosed, treated)*

197

203

200

Ever smoked*

‡

201

Ever used alcohol*

Age (Years)

203

Institutional Residence*

203

Female*
203

203

HbA1c (%)

African-American*

N

Variable

10.9

100.6

38.4%

16.7%

21.2%

2.7%

2.0%

27.6%

43.8%

46.9%

9.4%

25.9%

48.3%

17.7%

58.6%

29.0%

19.4%

61.1%

16.7%

85.2%

5.7

M/%

3.8

2.0

SD

HbA1c< 6.5 and no
hypoglycemics

29

29

29

28

28

24

29

29

26

26

26

26

28

29

29

29

29

29

29

29

28

N

9.1

100.5

41.4%

14.3%

10.7%

0.0%

6.9%

20.7%

42.3%

42.3%

15.4%

57.7%

78.6%

24.1%

79.3%

20.7%

31.0%

69.0%

44.8%

79.3%

7.0

M/%

4.0

2.2

SD

HbA1c≥ 6.5 and/or
hypoglycemics

NIH-PA Author Manuscript

Descriptive Statistics by Type 2 Diabetes Status

0.020

0.870

0.839

1.000

0.310

1.000

0.165

0.508

0.668

0.002

0.004

0.444

0.041

0.507

0.150

0.540

0.002

0.414

---

p value
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Table 1
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194
194
201
190
194
194
194
183

Serum glucose (non-fasting,
§
mg/dl)
‡
Serum creatinine (mg/dl)
‡
Hemoglobin (g/l)
‡
Ferritin (ng/ml)
‡
BUN (mg/dl)
‡
AST (iu/l)
‡
ALT (iu/l)
‡
C-reactive protein (mg/l)
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t-test for unequal variances

t-test for equal variances
§

‡

Wilcoxon Signed Rank Test

†

Fisher’s Exact Test

*

ALT = Aspartate aminotransferase

AST = Alanine aminotransferase

BUN = Blood urea nitrogen

APOE = Apolipoprotein E

HbA1c = Hemoglobin A1c

203

Number of non-hypoglycemic
†
medications

193

200

‡
Diastolic Blood Pressure (mmHg)
‡

201

†
Global Deterioration Rating Scale

Body Mass Index (kg/m2)

200

NIH-PA Author Manuscript
§
Systolic Blood Pressure (mmHg)

9.7

13.6

21.3

25.0

117.8

121.2

1.1

103.7

7.0

22.6

73.7

4.0

127.8

18.6

5.4

5.8

10.8

171.8

14.5

0.5

24.9

3.8

4.3

9.6

1.6

16.2

27

28

28

28

28

28

28

28

29

26

29

24

29

10.4

14.4

20.4

25.4

154.0

113.8

1.2

139.4

8.6

25.2

73.3

3.8

128.5

17.5

4.9

5.5

9.1

155.1

12.9

0.3

49.6

3.7

4.5

9.2

1.9

11.0

HbA1c≥ 6.5 and/or
hypoglycemics
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HbA1c< 6.5 and no
hypoglycemics

0.854

0.444

0.452

0.840

0.293

0.011

0.177

0.001

0.023

0.004

0.831

0.357

0.765
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Table 2
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Ordinary Least Squares Regression Model Predicting HbA1c Status
Variable

b*

SE(b)

p value

−0.023

0.024

0.338

Female

0.022

0.112

0.841

African-American

0.400

0.178

0.024

Institutional Residence

0.016

0.090

0.859

−0.002

0.014

0.866

0.044

0.012

0.001

0.163

0.110

0.138

Ever smoked

−0.237

0.093

0.011

Hypertension

0.081

0.083

0.333

Any APOE ε4

0.054

0.133

0.685

C-reactive protein (mg/l)

0.002

0.003

0.432

Intercept

7.046

2.401

0.003

Age (Years)

Education (Years)
Body Mass Index

(kg/m2)

Ever used alcohol
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χ2(11)=39.61, p<.001
HbA1c = Hemoglobin A1c
APOE = Apolipoprotein E
*

Entries are regression coefficients.
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